human
cell
complex
network
membran
protein
enclos
membran
lipid
bilay
interact
within
associ
biomembran
bilay
profound
consequ
organ
whole
singl
defect
potenti
gene
product
made
cell
caus
devast
fatal
evect
whole
organ
addit
human
pass
genet
inform
onto
ovspr
genet
mutat
polymorph
believ
least
peopl
eventu
develop
diseas
caus
mutat
variat
gene
level
understand
genet
mutat
increas
risk
human
diseas
critic
understand
treatment
major
human
ailment
caus
interact
organ
environ
review
focus
research
undertaken
past
year
relat
molecular
mechan
underli
membran
trayck
within
eukaryot
cell
address
mechan
factor
control
protein
progress
secretori
intern
pathway
highlight
key
human
diseas
illumin
mechan
membran
trayck
addit
current
futur
strategi
therapeut
intervent
genet
disord
consid
common
eukaryot
cell
presenc
multipl
biomembran
lipid
bilay
compart
organel
maintain
specif
proteinprotein
proteinlipid
interact
interact
maintain
within
compart
spite
continu
trayck
membranebound
solubl
compon
diver
intracellular
locat
secret
cell
major
case
transfer
materi
occur
vesicular
movement
fission
dock
fusion
membran
bilayerenclos
intermedi
occur
donor
acceptor
compart
palad
protein
includ
membranebound
receptor
secret
enzym
antibodi
begin
journey
enter
earli
secretori
pathway
endoplasm
reticulum
er
transport
golgi
apparatu
final
distribut
final
destin
intracellular
organel
plasma
membran
extracellular
environ
specif
protein
know
reach
specif
cellular
destin
hundr
newli
synthes
diver
molecul
requir
specif
transport
target
mani
transport
intermedi
vesicl
whether
deriv
er
intern
organel
plasma
membran
coat
uniqu
protein
complex
tether
factor
regulatori
factor
ensur
correct
target
acceptor
compart
vesicl
coat
protein
clathrin
coat
protein
cop
complex
rel
well
studi
complex
assembl
onto
cytoplasm
face
donor
compart
facilit
fission
transport
intermedi
alli
coat
protein
diver
molecul
mediat
recognit
cytoplasm
motif
cargo
protein
either
directli
eg
transmembran
protein
indirectli
eg
solubl
secret
enzym
snare
hypothesi
central
understand
vesicular
target
intracellular
compart
rothman
sollner
et
al
initi
uncov
screen
intragolgi
transport
dock
fusion
regul
snare
solubl
nethylmaleimidesensit
fusion
attach
protein
receptor
protein
found
regul
diver
membran
interact
eukaryot
via
highli
conserv
mechan
membran
trayck
base
accessori
dock
fusion
regul
snare
protein
present
vesicl
vesicular
vsnare
acceptor
target
tsnare
compris
coiledcoil
domain
assembl
facilit
vesicl
dock
membran
fusion
bennett
pelham
conjunct
snare
protein
small
rasrel
rab
gtpase
implic
ensur
fidel
vesicl
dock
fusion
olkkonen
stenmark
protein
gtphydrolyz
enzym
act
recruit
diver
protein
evector
membran
gtpgdpregul
manner
collin
rab
gtpase
activ
protein
conform
regul
interact
solubl
membranebound
protein
regul
also
tether
vesicl
acceptor
membran
mediat
intracellular
signal
earli
secretori
pathway
endoplasm
reticulum
er
first
stage
qualiti
control
along
secretori
pathway
protein
destin
secret
eg
hormon
plasma
membran
eg
membranebound
receptor
intracellular
membran
compart
lysosom
eg
lysosom
proteas
emphysema
liver
cirrhosi
perlmutt
endophillin
ii
clathrinco
pit
format
leukemia
dreyl
et
al
jone
et
al
narita
et
al
tebar
et
al
alzheim
diseas
presenilin
presenilin
cleavag
traffick
amyloid
precursor
protein
plasma
membran
neurodegen
disord
uemura
et
al
tau
tau
microtubular
stabil
format
aggreg
autosom
domin
polycyst
kidney
diseas
adpkd
caus
defect
ecadherin
assembl
basolater
traffick
renal
cyst
kidney
tissu
lead
endstag
renal
failur
charron
et
al
continu
autosom
domin
retin
pigmentosa
rhodopsin
inhibit
interact
rhodopsin
lead
inhibit
postgolgi
deliveri
rod
outer
segment
narrow
visual
field
night
blind
deret
et
al
autosom
domin
ventricular
tachycardia
cardiac
arrhythmia
hyperthermia
yano
et
al
autosom
recess
primari
hyperoxaluria
mistarget
peroxisom
protein
mitochondria
kidney
diseas
danpur
ablipoproteinaemia
mtp
er
retent
thu
prevent
apob
secret
vascular
diseas
sharp
et
al
batten
diseas
group
gene
product
implic
regul
process
target
lysosom
synapt
protein
neurolog
diseas
pearc
breast
cancer
delet
domin
neg
mutat
promot
tumor
progress
breast
cancer
boura
et
al
william
lisanti
hayasaka
et
al
matsuyama
et
al
chediakhigashi
syndrom
ch
lyst
involv
regul
protein
secret
lysosom
enlarg
lysosom
partial
albin
recurr
bacteri
infect
impair
chemotaxi
abnorm
natur
killer
cell
function
shiflett
et
al
ward
et
al
choroideremia
chm
rab
escort
protein
remain
cytosol
due
defect
geranylgeranyl
modif
chm
lymphoblast
xlink
form
retin
degener
combin
factor
v
viii
defici
ctype
lectin
er
retent
defect
secret
factor
v
viii
blood
diseas
congenit
finnish
nephrit
syndrom
nephrin
podocin
er
retent
kidney
inflamm
kestila
et
al
kramer
zucker
et
al
pancreat
atpsensit
potassium
channel
katp
er
golgi
retent
katp
due
mutat
subunit
excess
insulin
lead
hypoglycaemia
dunn
et
al
yan
et
al
congenit
hypothyroid
goiter
thyroglobulin
er
storag
diseas
thyroglobulin
misfold
accumul
er
constip
larg
tongu
swell
around
eye
failur
suckl
mental
retard
hishinuma
et
al
kim
arvan
fan
et
al
garman
garboczi
famili
hemophagocyt
lymphoschistiocytosi
fhl
perforin
defect
ctl
cytotox
lymphocyt
mediat
kill
immunodefici
feldmann
et
al
stepp
et
al
munc
hogg
et
al
mathew
et
al
three
form
menk
diseas
aris
diver
mutat
gene
prematur
stop
codon
delet
splice
defect
prevent
function
andor
trayck
classic
menk
diseas
common
fatal
usual
result
age
year
two
nonfat
form
menk
mild
occipit
horn
syndrom
maintain
abil
transport
copper
ion
across
intracellular
membran
although
trayck
plasma
membran
compromis
la
fontain
et
al
ubiquit
express
major
copper
transport
cell
intestin
kidney
brain
liver
howev
major
copper
transport
wilson
diseas
protein
bull
et
al
second
ptype
atpas
share
strong
similar
also
transloc
copper
ion
across
membran
although
gene
product
share
function
similar
mutat
result
copper
accumul
liver
brain
famili
hypercholesterolemia
autosom
dominantli
inherit
diseas
caus
mutat
lowdens
lipoprotein
receptor
ldlr
lead
prematur
atherosclerosi
coronari
heart
diseas
healthi
individu
ldlr
express
surfac
cell
bind
circul
ldl
particl
promot
uptak
cellular
metabol
constitu
includ
cholesterol
patient
ldlr
allel
display
amino
acid
substitut
cassanelli
et
al
jensen
et
al
truncat
lehrm
et
al
mi
sens
mutat
ion
leiter
sdorf
et
al
result
er
retent
degrad
point
mutat
residu
insulin
receptor
compromis
abil
receptor
dimer
correctli
within
er
therefor
lead
er
retent
decreas
plasma
membran
level
insulin
receptor
caus
inhibit
insulin
bind
stimulu
meal
subsequ
elev
plasma
glucos
level
lead
type
ii
diabet
mellitu
kadowaki
et
al
number
human
diseas
induc
er
stress
respons
mutant
protein
retain
within
er
result
either
dilat
organel
congenit
hyperthyroid
medeirosneto
et
al
hypofibrinogenemia
callea
et
al
chronic
er
stress
case
hereditari
emphysema
perlmutt
pelizaeusmerzbach
diseas
xlink
leukodystrophi
diseas
er
accumul
proteolipid
protein
plp
result
oligodendrocyt
apoptosi
gow
et
al
subsequ
disrupt
white
matter
format
brain
observ
human
mous
model
plp
central
nervou
system
protein
major
compon
myelin
express
cultur
fibroblast
local
plasma
membran
gow
et
al
link
plp
er
stress
respons
provid
tool
elucid
cellular
respons
misfold
protein
accumul
accumul
protein
within
er
lead
blockag
protein
secret
unwant
cellular
properti
mechan
evolv
overcom
event
dispos
unwant
protein
term
erassoci
degrad
erad
fig
recent
earli
still
believ
aberr
protein
degrad
within
er
fra
sitia
howev
current
model
suggest
aberr
erretain
protein
actual
undergo
retrotransloc
subsequ
degrad
cytoplasm
retrotransloc
propos
occur
pore
use
transloc
nascent
protein
er
lumen
translat
name
translocon
bieder
et
al
misch
variou
yeast
mammalian
protein
shown
retrotransloc
er
degrad
within
cytoplasm
proteasomedepend
manner
includ
bud
yeast
protein
carboxypeptidas
mutant
proafactor
mammalian
protein
cftr
express
bud
yeast
matur
rel
slowli
within
yeast
er
lead
retrotransloc
cytoplasm
degrad
ward
et
al
exampl
antitrypsin
defici
antitrypsin
respons
inactiv
enzym
elastas
produc
lung
neutrophil
inherit
diseas
mutat
form
antitrypsin
retrotransloc
degrad
proteasom
lead
retent
activ
elastas
lung
tissu
thu
caus
lung
emphysema
rutishaus
spiess
howev
retrotransloc
proteasom
degrad
may
function
coupl
process
pharmacolog
inhibitor
caus
proteasom
inactiv
lead
egress
molecul
mhc
class
wiertz
et
al
b
ribophorin
de
virgilio
et
al
carboxypeptidas
bieder
et
al
er
cell
cytoplasm
contrast
inhibit
protein
ubiquitin
result
retent
molecul
within
er
schmitz
et
al
suggest
two
distinct
proteasomeregul
pathway
mediat
degrad
retrotransloc
bamyloid
precursor
protein
interestingli
endocytos
toxin
target
key
cytosol
factor
appear
use
erad
pathway
move
er
cytosol
deek
et
al
haze
read
cholera
ricin
toxin
rout
cell
surfac
golgi
apparatu
er
retrotransloc
cell
cytosol
believ
unusu
low
lysin
content
protein
toxin
prevent
subsequ
erassoci
ubiquitin
degrad
cytosol
proteasom
protein
cargo
shuttl
er
golgi
within
vesicular
intermedi
spheric
vesicl
contain
coat
protein
complex
fig
qualiti
control
protein
assembl
within
endoplasm
reticulum
protein
destin
secretori
pathway
exampl
show
transmembran
protein
cotransl
transloc
ribosom
lumen
endoplasm
reticulum
er
portal
refer
translocon
newli
synthes
protein
enter
er
qualiti
control
mechan
form
protein
chaperon
bind
fold
correct
conform
process
occur
interact
chaperon
success
fold
protein
load
copiico
vesicl
shuttl
er
golgi
apparatu
howev
protein
carri
mutat
caus
take
aberr
conform
er
chaperon
trigger
misfold
protein
respons
two
outcom
either
chaperon
remain
bound
misfold
protein
prevent
escap
organel
er
retent
protein
ubiquitin
retrotransloc
complex
proteasom
degrad
cell
cytoplasm
number
human
genet
diseas
result
key
protein
fail
trayc
secretori
pathway
consequ
retain
degrad
manner
copi
copii
initi
discov
mammal
yeast
kaiser
schekman
malhotra
et
al
novick
et
al
rothman
wieland
cop
complex
requir
format
vesicl
er
ergolgi
intermedi
compart
ergic
golgi
apparatu
cop
recruit
membran
facilit
specif
captur
packag
transport
deliveri
membranebound
solubl
protein
cargo
acceptor
compart
copii
recruit
site
smooth
er
initi
format
anterograd
forward
transport
vesicl
copii
vesicl
move
er
ergic
vesicular
tubular
cluster
vtc
copico
vesicl
thought
mediat
continu
anterograd
movement
ergic
ci
face
golgi
apparatu
scale
et
al
gtpase
regul
copii
vesicl
format
via
interact
guanin
exchang
factor
gef
activ
gtpbound
form
lead
recruit
heterodim
membran
also
initi
protein
cargo
select
within
er
recruit
vsnare
bind
mediat
recruit
complex
copii
complex
act
protein
scavold
caus
deform
membran
result
vesicular
fission
anterograd
movement
protein
cargocontain
copii
vesicl
ergic
copii
dock
acceptor
compart
thought
trigger
function
caus
conform
chang
gtp
hydrolysi
dissoci
uncoat
copii
complex
thu
copii
vesicl
dock
fusion
acceptor
compart
mediat
cognat
vsnare
tsnare
interact
kirchhausen
kuehn
et
al
matsuoka
et
al
tang
et
al
sever
hereditari
bleed
disord
call
combin
defici
factor
v
factor
viii
highlight
function
import
trayck
er
ergic
patient
defici
ergicloc
protein
display
defect
secret
factor
v
viii
clot
factor
mannosebind
lectin
act
cargo
receptor
recycl
er
ergic
neermanarbez
et
al
howev
patient
show
normal
level
defici
associ
protein
anoth
ergic
resid
interact
calciumdepend
manner
small
intestin
cell
call
enterocyt
absorb
fat
fatsolubl
vitamin
food
form
fatti
acid
monoglycerid
fat
enter
lumen
surfac
absorpt
enterocyt
free
divus
across
membran
emerg
basolater
surfac
particul
structur
refer
chylomicron
format
chylomicron
occur
within
er
golgi
apparatu
vesicular
transport
trayck
golgi
plasma
membran
chylomicron
retent
diseas
cmrd
anderson
diseas
neuromuscular
disord
cmrd
associ
gren
syndrom
cmrdmss
exampl
inherit
diseas
result
compromis
fat
absorpt
low
blood
cholesterol
sever
deplet
blood
chylomicron
level
jone
et
al
identifi
eight
mutat
gene
product
copii
compon
associ
lipid
absorpt
diseas
thu
strongli
implic
role
copii
vesicular
transport
system
movement
dietari
fat
intestin
circul
bloodstream
copii
mediat
anterograd
trayc
er
golgi
apparatu
howev
copi
vesicl
appear
function
primarili
retrograd
backward
transfer
protein
golgi
ergic
back
er
retrograd
trayc
necessari
recov
escap
er
resid
protein
coat
snare
protein
arriv
ergic
golgi
copii
vesicl
glycosyl
enzym
incorrectli
modifi
duden
lee
et
al
golgiassoci
copi
coatom
complex
seven
polypeptid
b
b
g
e
zcop
gene
product
interact
donor
membran
form
copi
vesicl
vesicl
format
trigger
gtpase
adpribosyl
factor
recruit
copi
coatom
donor
membran
transmembran
protein
contain
cytoplasm
lysinebas
motif
kkxx
kxkxx
solubl
protein
contain
ctermin
kdel
motif
recycl
copico
vesicl
golgi
apparatu
back
er
kdel
motif
present
solubl
er
chaperon
bip
protein
disulfid
isomeras
recogn
membranebound
kdel
receptor
majoul
et
al
case
cytoplasm
motif
transmembran
protein
recogn
bound
copi
coatom
promot
inclus
vesicl
destin
er
actin
microfila
also
involv
retrograd
transport
step
valderrama
et
al
golgier
step
regul
gtpase
nwasp
protein
luna
et
al
factor
previous
implic
actinlink
process
plasma
membran
live
imag
cell
express
engin
fluoresc
temperaturesensit
vesicular
stomat
viru
gglycoprotein
demonstr
sequenti
action
copiiand
copico
vesicl
scale
et
al
vsvg
accumul
structur
close
er
contain
intermedi
compart
resid
protein
structur
matur
vesicl
contain
copi
protein
stephen
et
al
show
segreg
copii
copi
vesicl
occur
locat
close
proxim
exit
site
er
membran
copindepend
mechan
also
implic
retrograd
trayc
golgi
apparatu
er
gtpase
implic
regul
movement
bacteri
shiga
toxin
b
fragment
stb
via
retrograd
step
golgi
apparatu
er
express
dominantneg
gdpbound
form
inhibit
stb
retrograd
movement
wherea
copi
transport
unavect
white
et
al
golgi
apparatu
compos
flatten
cisterna
membran
compart
close
juxtapos
stacklik
appear
mammalian
cell
stack
posit
endtoend
form
ribbonlik
structur
near
nucleu
barr
warren
golgi
apparatu
highli
dynam
organel
site
hub
secretori
pathway
key
process
sort
function
golgi
polar
structur
protein
lipid
er
receiv
ci
side
follow
medial
tran
subcompart
glycosyl
modif
occur
transgolgi
network
tgn
final
subcompart
sort
packag
event
take
place
golgi
apparatu
also
sort
protein
lipid
bound
retrograd
pathway
cisgolgi
back
er
addit
protein
also
return
tgn
endomembranelysosom
system
fig
controversi
exist
regard
mechan
anterograd
movement
cargo
protein
within
golgi
apparatu
golgi
apparatu
contain
secretori
protein
vari
physic
size
rel
small
polypeptid
larg
bulki
multisubunit
complex
need
reach
tgn
final
sort
transport
intermedi
also
resid
glycosyl
enzym
spatial
restrict
function
within
golgi
enzym
function
within
specif
subcompart
ensur
correct
addit
trim
nand
olink
sugar
secret
protein
progress
pathway
rais
key
question
protein
lipid
cargo
move
golgi
apparatu
resid
enzym
retain
local
know
mani
golgi
enzym
contain
transmembran
golgi
local
signal
mediat
target
specif
compart
munro
two
model
propos
cistern
matur
model
vesicular
transport
model
elsner
et
al
storri
et
al
briefli
cistern
matur
model
suggest
larg
protein
aggreg
remain
within
singl
golgi
cisterna
matur
retrograd
transfer
resid
enzym
via
copi
vesicl
contrast
vesicular
transport
model
propos
newli
synthes
protein
trayck
cisterna
cisterna
via
copico
vesicl
sequenti
bud
ov
membran
fuse
next
subcompart
either
case
copico
vesicl
play
central
role
intragolgi
secretori
pathway
vesicular
trayck
protein
enter
secretori
pathway
endoplasm
reticulum
er
trayck
copiico
vesicular
structur
intermedi
compart
ergicvtc
copico
vesicl
carri
ci
face
golgi
cargo
protein
c
continu
along
secretori
pathway
golgi
apparatu
transgolgi
network
tgn
retent
signal
er
resid
protein
r
ensur
undergo
retrograd
trayck
golgi
copi
vesicl
retrograd
transport
transport
number
snare
protein
membrin
also
local
golgi
apparatu
requir
intragolgi
transport
homeostasi
nichol
pelham
golgiteth
molecul
call
golgin
golgi
reassembl
stack
protein
grasp
belong
famili
regulatori
factor
involv
golgi
mainten
vesicular
transport
reader
point
indepth
review
cover
golgin
detail
short
et
al
brief
golgin
anchor
golgi
membran
variou
mechan
contain
characterist
coiledcoil
domain
extend
membran
rodlik
structur
burkhard
et
al
golgin
giantin
secur
anchor
membran
via
transmembran
domain
near
c
terminu
electrostat
ionic
interact
mediat
attach
golgin
membran
exampl
protein
grasp
famili
bind
recruit
factor
ci
medial
golgi
membran
respect
moreov
larg
number
golgin
recruit
membran
via
interact
rab
arf
arl
arflik
gtpase
vesicular
cisgolgi
membran
recruit
golgin
regul
wherea
membran
attach
yeast
golgin
regul
bind
membran
interact
member
new
class
arflik
gtpase
term
arl
short
et
al
interestingli
autoantibodi
direct
giantin
golgin
grasp
present
patient
autoimmun
condit
gren
syndrom
system
lupu
erythematosu
gren
syndrom
moistureproduc
gland
target
autoimmun
respons
result
dri
eye
mouth
lichtenfeld
et
al
system
lupu
erythematosu
chronic
rheumat
condit
avect
joint
muscl
caus
skin
rash
kidney
problem
gren
syndrom
patient
also
simultan
display
rheumatoid
arthriti
system
lupu
erythematosu
golgi
biogenesi
requir
golgin
function
diver
stage
cell
divis
mammalian
crucial
mainten
stack
natur
golgi
cisterna
puthenveedu
linstedt
mitosi
golgi
stack
dispers
cluster
vesicl
vesicl
fuse
daughter
cell
form
new
cisterna
align
stack
result
format
fulli
function
organel
tether
propos
hold
cisterna
close
proxim
interact
shorter
warren
golgin
also
involv
tether
copi
vesicl
golgi
membran
sonnichsen
et
al
may
need
snare
complex
assembl
shorter
et
al
bud
yeast
homolog
tether
copiico
vesicl
golgi
membran
anterograd
transport
er
exit
site
cisgolgi
barlow
cao
et
al
sapperstein
et
al
mammalian
also
essenti
tether
transport
vesicl
cisgolgi
alvarez
et
al
intragolgi
transport
seemann
et
al
water
et
al
golgin
implic
regul
golgi
structur
format
golgi
ribbon
diao
et
al
may
function
tether
molecul
retrograd
trayc
endosom
tgn
lu
et
al
moreov
golgin
also
implic
tether
compon
cytoskeleton
golgi
apparatu
short
et
al
transgolgi
network
tgn
final
golgi
subcompart
secret
protein
sort
packag
direct
final
destin
trayck
tgn
occur
either
constitut
regul
manner
constitut
transport
continu
releas
protein
transgolgi
network
regul
secret
occur
respons
extracellular
stimuli
secretagogu
metal
ion
hormon
growth
factor
trigger
dock
fusion
secretori
granul
vesicl
plasma
membran
variou
mechan
control
trayck
protein
tgn
format
deliveri
membranederiv
transport
vesicl
plasma
membran
endosom
lysosom
structur
ponnambalam
baldwin
express
inact
dominantneg
protein
kinas
isoform
tumor
line
liljedahl
et
al
polar
canin
kidney
cell
yeaman
et
al
mous
fibroblast
prigozhina
watermanstor
shown
inhibit
vesicl
fission
releas
tgn
vesicl
releas
modul
famili
kinas
respons
cellular
diacylglycerol
baron
malhotra
bind
yet
unknown
evector
protein
cytoplasm
face
tgn
van
lint
et
al
addit
gtpase
link
actin
remodel
shown
inhibit
exit
basolater
target
protein
polar
cell
kroschewski
et
al
musch
et
al
copperregul
protein
transport
cobbold
et
al
copper
essenti
element
cofactor
requir
function
mani
secret
enzym
cuproenzym
steadi
state
menk
howel
et
al
diseas
copper
transport
section
resid
tgn
provid
newli
synthes
cuproenzym
lysyl
oxidas
copper
ion
travers
secretori
pathway
intracellular
copper
ion
level
rise
respond
environment
danger
redistribut
plasma
membran
manner
cobbold
et
al
act
copper
ezux
pump
remov
copper
ion
cytoplasm
maintain
homeostat
function
prevent
toxic
copper
level
reduc
recycl
back
tgn
endocyt
intern
sort
event
independ
clathrin
caveola
cobbold
et
al
although
reli
cytoplasm
dileucin
motif
present
cterminu
petri
mercer
dent
diseas
xlink
kidney
disord
present
hypercalciuria
nephrocalcinosi
kidney
stone
format
progress
renal
failur
caus
missens
nonsens
delet
mutat
within
endosom
voltageg
chlorid
channel
member
larg
famili
voltageg
chlorid
channel
divers
array
cellular
function
includ
membran
excit
transepitheli
ion
transport
cell
volum
regul
thakker
express
xenopu
oocyt
number
missens
mutat
gene
local
channel
golgi
apparatu
show
reduc
conduct
significantli
reduc
plasma
membran
pm
local
ludwig
et
al
similarli
express
mutant
allel
cultur
cell
reveal
approxim
increas
golgi
retent
carr
et
al
receptormedi
endocytosi
clathrinco
vesicl
ccv
rout
protein
intern
conserv
yeast
human
roth
porter
first
observ
process
mosquito
oocyt
vesicl
subsequ
becom
one
best
character
membran
transport
step
eukaryot
clathrin
one
princip
protein
involv
transport
step
combin
clathrinassoci
factor
uniqu
structur
compon
form
transport
vesicl
cytoplasm
face
tgn
endosom
plasma
membran
clathrinco
vesicl
bud
donor
membran
direct
target
membran
associ
protein
factor
highli
conserv
clathrin
complex
compris
heavi
kda
light
kda
chain
protein
assembl
threeleg
structur
call
triskelion
triskelion
polymer
accessori
factor
strike
latticelik
cage
compris
pentagon
hexagon
resembl
soccer
ball
structur
buckminsterfulleren
clathrin
cage
nm
diamet
significantli
larger
copi
copii
vesicl
ccv
clathrinco
vesicl
believ
assembl
sequenc
event
design
activ
cargo
captur
coat
assembl
scission
movement
vesicl
uncoat
kirchhausen
member
class
clathrinassoci
factor
term
adaptor
protein
ap
complex
recruit
donor
membran
interact
dock
complex
interact
motif
within
cytoplasm
tail
cargo
protein
result
cargo
captur
lead
clathrin
cage
assembl
concomit
polymer
clathrin
triskelion
result
deform
donor
membran
scission
vesicl
releas
plasma
membran
believ
occur
action
gtpase
dynamin
accessori
protein
amphiphysin
wigg
et
al
fruit
fli
drosophila
melanogast
dynamin
gene
mutat
shibir
caus
temperaturesensit
paralysi
like
due
block
endocyt
uptak
synapt
vesicl
protein
plasma
membran
lead
block
recycl
reform
compet
synapt
vesicl
nerv
termin
chen
et
al
koenig
ikeda
kosaka
ikeda
van
der
bliek
meyerowitz
express
dominantneg
gdpbound
dynamin
mutant
result
compromis
ccv
format
herskovit
et
al
van
der
bliek
et
al
inhibit
clathrinmedi
intern
glucos
transport
alhasani
et
al
human
immunodefici
viru
hiv
daeck
et
al
influenza
viru
roy
et
al
scission
function
dynamin
assist
specif
lipidmodifi
enzym
endophilin
synaptojanin
phospholipas
bi
et
al
havner
et
al
ringstad
et
al
schmidt
et
al
woscholski
et
al
final
ccv
uncoat
target
membran
occur
action
heat
shock
protein
schlossman
et
al
auxilin
ungewickel
et
al
sort
protein
donor
target
membran
involv
recognit
cytoplasm
sequenc
membran
protein
clathrinassoci
ap
complex
four
adaptor
protein
complex
compris
four
diver
subunit
identifi
robinson
complex
involv
clathrinco
vesicl
format
tgn
transport
late
endosom
evid
also
implic
role
complex
tgntoplasma
membran
step
folsch
et
al
beststudi
four
complex
mediat
intern
transmembran
howel
et
al
receptor
plasma
membran
via
clathrinco
vesicl
complex
involv
trayck
earli
endosom
either
late
endosom
lysosomerel
organel
melanosom
plateletdens
bodi
antigenprocess
compart
final
complex
last
clone
dellangelica
et
al
hirst
et
al
contrast
possess
b
ear
domain
see
allow
interact
clathrin
cytosol
factor
auxilin
lundmark
carlsson
electron
microscopi
local
vesicl
tgn
plasma
membran
earli
endosom
although
debat
whether
vesicl
clathrinco
baroi
bakk
hirst
et
al
interestingli
may
function
independ
clathrin
hirst
et
al
vowel
payn
suggest
exist
anoth
yet
unidentifi
coat
protein
analog
clathrin
four
ap
complex
compris
two
larg
subunit
b
subunit
plu
g
e
subunit
addit
ap
complex
contain
subunit
small
subunit
contain
two
carboxyl
ear
domain
connect
head
larg
subunit
flexibl
hing
approxim
residu
importantli
ear
domain
b
subunit
hing
domain
g
subunit
shown
bind
clathrin
goodman
keen
morgan
et
al
owen
et
al
consensu
sequenc
hing
domain
clathrinbind
properti
dellangelica
et
al
b
subunit
ap
complex
interact
motif
present
cytoplasm
domain
transmembran
protein
mediat
cargo
recruit
clathrinco
vesicl
motif
includ
npxi
dileucinebas
sequenc
repres
bulki
hydrophob
amino
acid
one
motif
npxi
present
key
cellular
receptor
low
densiti
lipoprotein
receptor
ldlr
epiderm
growth
factor
receptor
egfr
insulin
receptor
mediat
endocytosi
sort
importantli
jd
mutat
ldlr
lie
within
key
motif
caus
famili
hypercholesterolemia
knoblauch
et
al
second
tyrosinebas
motif
mediat
plasma
membran
intern
lysosom
target
basolater
target
cargo
motif
found
lysosom
resid
recycl
transferrin
receptor
tfr
tgnassoci
recycl
membran
protein
furin
dileucin
motif
present
transmembran
transport
glucos
transport
receptor
fall
two
categori
de
xxx
li
dxxll
relat
motif
de
xxx
li
motif
associ
protein
intern
plasma
membran
target
lysosom
dxxll
motif
found
transmembran
protein
shuttl
tgn
endosom
system
bonifacino
traub
anoth
class
clathrinassoci
factor
golgiloc
gearcontain
arfbind
protein
gga
found
tgn
postul
interact
mediat
transport
section
vb
endosom
doray
et
al
gga
act
multifunct
adaptor
link
transmembran
protein
arf
gtpase
clathrin
accessori
protein
site
ccv
format
robinson
bonifacino
diseas
oculocerebroren
syndrom
low
ocrl
xlink
disord
caus
mutat
gene
low
gene
product
inositol
phosphatas
catalyz
remov
phosphat
posit
inositol
moieti
prefer
substrat
pi
p
phosphoinositid
shown
import
endocytosi
central
role
recruit
accessori
protein
ccv
padron
et
al
local
clathrinco
vesicl
associ
endosom
tgn
membran
choudhuri
et
al
surpris
interact
clathrin
promot
assembl
clathrin
lattic
cage
choudhuri
et
al
ungewickel
et
al
also
interact
gtpase
regul
actin
dynam
possibl
via
gtpase
activ
domain
acceler
gtp
hydrolysi
faucherr
et
al
although
exact
function
still
unclear
diseas
phenotyp
hint
function
membran
trayck
mutat
caus
loss
protein
express
phosphatas
activ
rnaimedi
inhibit
express
cultur
human
cell
result
partial
redistribut
cationindepend
receptor
tgn
recycl
protein
earli
endosom
choudhuri
et
al
suggest
loss
perturb
endosometotgn
vesicl
transport
suggest
function
requir
membran
trayc
step
possibl
play
role
anterograd
trayck
tgntoendosom
well
sinc
abundantli
present
tgnassoci
clathrin
bud
destin
endocyt
pathway
ocrl
diseas
symptom
includ
congenit
cataract
mental
retard
renal
tubular
dysfunct
low
et
al
renal
failur
ocrl
patient
probabl
partli
caus
defect
solut
protein
readsorpt
kidney
proxim
tubul
like
due
missort
megalin
cubilin
cell
surfac
receptor
involv
kidney
solut
uptak
patient
plasma
membran
shed
receptor
reduc
norden
et
al
indic
regul
either
receptor
trayck
tgntoplasma
membran
recycl
plasma
membranetotgn
paraneoplast
stivperson
syndrom
sp
neurolog
autoimmun
diseas
character
sever
muscl
stiv
spasm
often
secondari
symptom
includ
diabet
epilepsi
breast
cancer
autoantibodi
produc
clathrinassoci
regul
amphiphysin
de
camilli
et
al
protein
shown
bind
dynamin
nerv
termin
david
et
al
implic
regul
endocytosi
neuron
synapt
vesicl
compon
burn
support
hypothesi
sommer
et
al
show
spslike
symptom
could
trigger
rat
inject
antiamphiphysin
antibodi
human
sp
patient
genet
transloc
lead
format
hybrid
clathrinaccessori
protein
lead
form
acut
myeloid
leukemia
lymphoblast
leukemia
acut
megakaryoblast
leukemia
dreyl
et
al
jone
et
al
narita
et
al
tebar
et
al
diseas
aberr
hybrid
protein
consist
put
transcript
factor
clathrin
accessori
protein
calm
clathrin
assembl
lymphoid
myeloid
leukemia
protein
form
partial
invers
gene
chromosom
salmonnguyen
et
al
final
hermanskypudlak
syndrom
hp
type
condit
result
partial
albin
prolong
bleed
mutat
found
gene
encod
subunit
adaptor
complex
dellangelica
et
al
hp
discuss
detail
section
vc
origin
identifi
year
ago
palad
yamada
caveola
flaskshap
invagin
approxim
nm
diamet
plasma
membran
plasma
membran
profil
relat
lipid
raft
contain
uniqu
mixtur
gpianchor
protein
transmembran
protein
signal
factor
lipid
cholesterol
caveola
believ
mediat
uptak
small
solut
regul
protein
trayck
hommelgaard
et
al
tagawa
et
al
transcytosi
transport
across
endotheli
cell
simionescu
et
al
signal
transduct
insel
et
al
lisanti
et
al
ostrom
insel
cholesterol
homeostasi
field
field
howev
exact
role
intern
membran
protein
solubl
protein
ligand
controversi
also
known
structur
compon
essenti
format
stabil
caveola
kurzchalia
et
al
rothberg
et
al
three
member
caveolin
gene
famili
tang
et
al
abund
wide
varieti
cell
type
includ
endotheli
cell
adipocyt
alveolar
type
pneumocyt
smooth
muscl
cell
william
lisanti
wherea
musclespecif
isoform
express
striat
muscl
cell
cardiac
skelet
myocyt
cohen
et
al
tang
et
al
abl
induc
format
caveola
plasma
membran
galbiati
et
al
li
et
al
howev
requir
presenc
express
membran
local
format
caveola
razani
et
al
caveola
absent
cell
lack
induc
ectop
express
gene
fra
et
al
caveolin
adopt
hairpinlik
structur
insert
membran
n
c
termini
cytoplasm
caveolin
polymer
form
striat
coat
surround
invagin
site
bind
cholesterol
murata
et
al
enrich
within
caveola
lipid
raft
sargiacomo
et
al
may
explain
caveola
consid
subset
lipid
raft
howev
caveola
lipid
raft
consid
independ
entiti
protein
found
one
liu
et
al
certain
ligand
intern
via
lipid
raftdepend
clathrinindepend
mechan
cell
lack
caveola
lamaz
et
al
larg
pool
plasma
membran
caveolar
vesicl
cluster
dens
grapelik
structur
individu
caveola
appear
stack
top
anoth
thomsen
et
al
structur
intim
associ
actin
cytoskeleton
stahlhut
van
deur
caveolaassoci
protein
also
implic
regul
plasma
membran
dynam
cellular
movement
small
pool
transportcompet
caveolar
vesicl
may
undergo
shortrang
constitut
fusion
bud
cycl
plasma
membran
caveola
caveolin
also
detect
tgn
dupre
et
al
kurzchalia
et
al
may
form
stabl
platform
movement
protein
lipid
tgn
plasma
membran
tagawa
et
al
caveolar
pathway
hijack
use
pathogen
toxin
gain
entri
cell
virus
polyomaviru
echoviru
simian
viru
use
caveola
intern
viral
particl
virus
cluster
lipid
raft
sequest
caveola
interact
raft
compon
integrin
glycosphingolipid
case
viru
bind
raft
compon
gangliosid
gm
tsai
et
al
tagawa
et
al
shown
trigger
longrang
movement
transportcompet
caveolar
vesicl
moreov
cell
infect
doubl
number
caveola
capabl
undergo
viral
intern
longrang
trayck
caveola
contain
much
molecular
machineri
requir
classic
vesicl
fission
dock
fusion
exampl
snare
protein
monomer
trimer
gtpase
annexin
ii
vi
nethylmaleimid
nem
sensit
fusion
protein
nsf
atpas
schnitzer
et
al
caveola
also
contain
dynamin
gtpase
transient
recruit
caveola
implic
membran
scission
henley
et
al
oh
et
al
pelkman
heleniu
intern
caveoladeriv
vesicl
move
endocyt
compart
term
caveosom
eventu
arriv
earli
endosom
fusion
target
compart
caveola
disassembl
maintain
integr
membran
preserv
compartment
retain
lipid
protein
compon
pelkman
et
al
fate
intern
virus
reach
caveosom
eventu
result
arriv
smooth
er
pelkman
et
al
interestingli
mutat
caveolin
implic
muscular
dystrophi
cardiovascular
diseas
mutat
caus
downregul
caveolin
link
progress
variou
human
carcinoma
therefor
possibl
caveolin
may
tumor
suppressor
role
gene
locat
human
near
microsatellit
repeat
marker
region
commonli
delet
variou
cancer
engelman
et
al
hint
caveolin
gene
delet
may
advantag
tumor
progress
one
report
mutat
present
breast
cancer
patient
studi
hayashi
et
al
mutat
also
link
metastat
potenti
tumor
diseas
prognosi
mutat
also
confer
increas
cell
migrat
alter
morpholog
protein
level
reduc
absent
number
human
breast
cancer
cell
line
compar
normal
mammari
cell
lee
et
al
similarli
silent
missens
mutat
also
associ
oral
carcinoma
han
et
al
lesser
extent
gene
express
downregul
case
thyroid
carcinoma
aldr
et
al
although
remain
unclear
loss
caveolin
caus
cell
prolifer
diseas
cancer
one
specul
role
caveolin
regul
signal
pathway
endotheli
cell
high
abund
caveolin
key
vascular
endotheli
growth
factor
receptor
shown
inact
local
caveola
labrecqu
et
al
receptor
tyrosin
kinas
modul
endotheli
respons
key
vegfa
cytokin
control
angiogenesi
new
blood
vessel
format
thu
regul
neovascular
tumor
growth
neufeld
et
al
similarli
plateletderiv
growth
factor
pdgf
receptor
tyrosin
kinas
activ
reduc
associ
caveola
yamamoto
et
al
addit
pdgfr
number
g
proteincoupl
receptor
gpcr
shown
interact
caveolaassoci
factor
insel
et
al
gpcr
larg
famili
transmembran
receptor
involv
varieti
signal
transduct
event
receptor
activ
rang
ligand
includ
hormon
peptid
link
number
cancer
cell
biolog
membran
traffick
human
diseas
thyroid
lung
gastric
presenc
number
gpcr
caveola
suggest
plasma
membran
structur
may
interact
gpcr
modul
signal
potenti
lisanti
other
li
et
al
shown
interact
sole
inact
form
gprotein
subunit
lend
credenc
neg
regul
hypothesi
caus
associ
caveola
transmembran
signal
receptor
number
mutat
musclespecif
associ
four
distinct
relat
autosom
domin
muscl
diseas
phenotyp
woodman
et
al
limb
girdl
muscular
dystrophi
type
minetti
et
al
rippl
muscl
diseas
hyperckemia
persist
elev
level
serum
creatin
kinas
distal
myopathi
mutat
caus
aberr
retent
golgi
subsequ
degrad
mutat
may
caus
mutant
act
dominantneg
manner
form
unstabl
aggreg
wildtyp
galbiati
et
al
sotgia
et
al
b
hypertroph
cardiomyopathi
hcm
patient
mutat
reduc
plasma
membran
level
hayashi
et
al
caveolin
gene
knockout
mice
provid
insight
protein
function
diver
human
diseas
exampl
lack
caveolin
caus
diabet
atherosclerosi
cardiomyopathi
mous
model
cohen
et
al
william
lisanti
howev
phenotyp
yet
link
caveolin
dysfunct
human
phagocytosi
process
use
white
blood
cell
macrophag
neutrophil
dendrit
ingest
larg
particul
materi
special
vesicl
call
phagosom
profession
phagocyt
paramount
defens
infect
engulf
ingest
whole
microorgan
bacteria
also
use
rout
mop
apoptot
debri
senesc
cell
tissu
contrast
constitut
pinocyt
transport
phagocytosi
regul
cell
surfaceloc
fc
receptor
fcr
contact
interact
complementor
antibodyco
particl
result
cluster
fcr
cell
surfac
step
import
subsequ
intracellular
signal
cellular
activ
daeron
polymorph
leukocytespecif
fcg
receptor
may
contribut
autoimmun
diseas
syndrom
rheumatoid
arthriti
enhanc
suscept
infect
van
sorg
et
al
fcmediat
bind
trigger
complex
signal
respons
involv
extrus
fine
plasma
membran
project
pseudopodia
macrophag
surround
engulf
pathogen
form
phagosom
signal
respons
review
greater
detail
elsewher
bokoch
chimini
chavrier
niedergang
chavrier
brief
activ
tyrosin
kinas
rho
gtpase
trigger
fcr
signal
rac
gtpase
conjunct
downstream
evector
wasp
mediat
remodel
actin
cytoskeleton
lead
pseudopodium
format
phagosom
closur
castellano
et
al
chimini
chavrier
contrast
complement
mediateduptak
opson
particl
diver
appear
fall
cell
process
requir
rho
rac
bokoch
phagocytosi
although
design
destroy
pathogen
paradox
use
rout
entri
pathogen
mycobacterium
lepra
tuberculosi
leishmania
nguyen
pieter
scott
et
al
normal
intern
pathogen
destroy
success
phagosom
matur
lysosom
subsequ
degrad
mycobacterium
evad
host
degrad
secret
solubl
serinethreonin
protein
kinas
g
molecul
phagosom
molecul
initi
signal
respons
interfer
phagosomelysosom
fusion
promot
intracellular
pathogen
surviv
walburg
et
al
furthermor
phagosom
matur
compromis
pathogen
induc
block
map
mitogenactiv
protein
kinas
recruit
tether
molecul
earli
endosom
antigen
fratti
et
al
leishmania
protozoan
parasit
transmit
human
sand
fli
produc
membran
molecul
call
lipophosphoglycan
insert
lipid
bilay
phagosom
infect
macrophag
lipophosphoglycan
thought
modul
intracellular
signal
pathway
result
less
fusogen
phagosom
prevent
matur
would
facilit
pathogen
replic
diseas
progress
lodg
descoteaux
molecul
intern
cell
surfac
receptormedi
endocytosi
clathrinco
vesicl
deliv
earli
endosom
sort
molecul
lowdens
lipoprotein
receptor
ldlr
transferrin
receptor
tfr
eycient
recycl
earli
endosom
plasma
membran
howev
ligandmedi
activ
fig
receptor
tyrosin
kinas
epiderm
growth
factor
receptor
egfr
sort
along
endocyt
pathway
degrad
earli
endosom
thought
form
fusion
intern
vesicl
recruit
specif
protein
lipid
one
key
protein
trayck
endosomallysosom
system
cell
surfac
receptor
intern
clathrinco
vesicl
ccv
plasma
membran
cell
cytoplasm
ccv
shed
coat
compon
fuse
produc
endosom
intern
receptor
either
recycl
sort
endosom
housekeep
receptor
eg
transferrin
receptor
target
degrad
within
lysosom
signal
receptor
eg
growth
factor
receptor
movement
late
endosom
multivesicular
bodi
mvb
compart
endosom
regul
ubiquit
express
gtpase
present
cytosol
face
plasma
membran
vesicl
tubular
endosom
profil
chavrier
et
al
number
evector
protein
regul
endosom
fusion
mediat
protein
cargo
movement
endosom
sort
zerial
mcbride
evector
protein
includ
cluster
cytosol
face
earli
endosom
stabil
gtpbound
activ
state
horiuchi
et
al
gtpbound
directli
bind
earli
endosom
antigen
regul
vesicular
endosom
tether
contain
ctermin
domain
phosphatidylinositol
zinc
finger
domain
refer
fyve
conserv
yotb
domain
gaullier
et
al
stenmark
et
al
overexpress
wildtyp
constitut
activ
mutant
caus
endosom
enlarg
defect
trayck
compart
wherea
express
constitut
inact
mutant
lead
format
small
endosom
decreas
endocytosi
bucci
et
al
famili
evector
protein
acceler
gtpase
hydrolysi
rabgap
identifi
bind
regul
trayck
endocyt
pathway
import
activ
illustr
genet
disord
tuber
sclerosi
ts
diseas
caus
tumor
brain
eye
heart
kidney
lung
skin
ts
aris
tumor
suppressor
gene
tuber
sclerosi
complex
tsc
absent
introduct
wildtyp
gene
anim
model
cultur
cell
result
tumor
suppress
reduc
cellular
prolifer
kobayashi
et
al
yeung
et
al
interestingli
gene
product
tuberin
implic
regul
gtpgdp
exchang
thu
regul
trayck
endosom
system
xiao
et
al
chronic
myelomonocyt
leukemia
cmml
genet
transloc
caus
fusion
evector
pdgfbr
magnusson
et
al
chromosom
transloc
result
enhanc
cellular
prolifer
compromis
endosom
fusion
trayck
thu
regul
growth
factor
degrad
like
aberr
gene
product
degrad
trigger
sustain
intracellular
signal
lead
cell
prolifer
tumor
progress
subset
lymphoid
cell
recycl
endosom
back
cell
surfac
often
use
receptor
intern
nutrient
lipoprotein
ion
receptor
recycl
rather
degrad
conserv
receptor
function
nutrient
uptak
reduc
energi
expenditur
synthesi
new
receptor
mukherje
et
al
genet
screen
nematod
caenorhabd
elegan
identifi
delin
new
famili
conserv
class
homolog
eh
domain
protein
worm
mous
homolog
associ
endosom
compart
dominantneg
mutant
littl
evect
receptormedi
endocytosi
substanti
evect
endosom
recycl
suggest
function
role
step
although
inform
current
limit
number
neurolog
diseas
associ
dysfunct
earli
endosom
protein
case
demyelin
polyneuropathi
character
progress
weaken
sensori
dysfunct
leg
arm
autoantibodi
detect
selak
et
al
number
disord
muscular
dystrophi
rheumatoid
arthriti
reveal
presenc
circul
antibodi
interestingli
epitop
recogn
autoantibodi
vari
patient
patient
selak
et
al
autoantibodi
also
detect
case
subacut
cutan
system
lupu
erythematosu
scle
character
appear
unsightli
red
rash
often
occur
sun
exposur
mu
et
al
lysosom
termin
membraneenclos
degrad
compart
interact
organel
vesicular
transport
origin
secretori
endocyt
autophag
pathway
organel
store
variou
proteas
lipas
hydrolas
degrad
enzym
within
acid
environ
maxim
enzymat
activ
degrad
resid
lysosom
membran
protein
integr
protein
glycoprotein
target
organel
via
endosom
lysosom
proteas
cathepsin
process
golgi
apparatu
add
mannos
moieti
nlink
sugar
moieti
recogn
plasma
membran
tgnresid
mannos
receptor
sort
late
endosom
eventu
lysosom
acid
ph
ph
result
receptorligand
disassoci
recycl
tgn
fusion
endosom
preexist
primari
lysosom
allow
deliveri
lysosom
resid
protein
import
target
lysosom
protein
highlight
human
neurolog
disord
icel
diseas
mucolipidosi
ii
lysosom
enzym
secret
cell
rather
target
lysosom
defect
icel
diseas
involv
lack
moieti
addit
result
mutat
enzym
usual
present
within
golgi
apparatu
benyoseph
et
al
lysosom
form
still
unclear
luzio
et
al
three
mechan
propos
explain
lysosom
biogenesi
vesicular
transport
late
endosom
preform
primari
lysosom
griyth
gruenberg
earli
endosom
matur
lysosom
murphi
current
favor
model
kissandrun
transient
interact
endosom
lysosom
transfer
endosom
content
latter
compart
duclo
et
al
storri
desjardin
late
endosom
lysosom
interact
kissandrun
model
thought
regul
gtpase
present
late
endosom
vp
complex
homolog
bud
yeast
vacuol
fusion
regul
also
implic
sort
deliveri
lysosom
seal
et
al
mammalian
form
vp
complex
interact
tsnare
concern
regul
membran
dynam
along
rout
kim
et
al
danon
diseas
caus
point
mutat
complet
absenc
lysosomeassoci
membran
protein
complet
absenc
protein
chang
result
cardiomyopathi
myopathi
mental
retard
danon
diseas
patient
mice
autophag
vacuol
accumul
within
cytoplasm
vacuol
aris
via
intracellular
engulf
old
membran
form
autophagosom
thu
sequest
membran
protein
eventu
degrad
shintani
klionski
autophagosom
fuse
lysosom
lead
degrad
provis
molecul
cellular
homeostasi
accumul
autophag
vacuol
cell
suggest
mediat
interact
autophagosom
lysosom
pathway
commonli
activ
condit
cellular
stress
starvat
pathogen
infect
kirkegaard
et
al
lysosom
storag
diseas
caus
insuffici
degrad
target
compon
within
lysosom
lead
substrat
accumul
lysosom
enlarg
lysosom
storag
diseas
document
gener
manifest
neurolog
disord
diseas
sever
correl
level
lysosom
enzym
activ
niemannpick
diseas
neurodegen
condit
caus
sphingomyelin
accumul
reticuloendotheli
cell
ganglion
neuron
lead
cell
death
classifi
five
type
ae
distinguish
either
clinic
sever
agerel
diseas
phenotyp
niemannpick
type
npa
common
death
occur
year
age
npa
patient
point
mutat
gene
encod
lysosom
sphingomyelinas
levran
et
al
takahashi
et
al
interestingli
npc
patient
endocytos
ldl
particl
fulli
degrad
lysosom
lead
defect
cholesterol
metabol
li
et
al
npc
diseas
caus
mutat
gene
encod
lysosom
resid
protein
similar
sterolsens
enzym
protein
scott
ioannou
fabri
diseas
xlink
condit
caus
chang
lysosom
agalactosidas
activ
result
glycosphingolipid
accumul
within
vascular
endotheli
lysosom
lead
angiokeratoma
wartlik
thicken
skin
progress
renal
impair
cardiomyopathi
cerebrovascular
diseas
mutat
agalactosidas
gene
also
show
reduc
enzymat
activ
encod
protein
retent
within
endoplasm
reticulum
yasuda
et
al
receptor
tyrosin
kinas
epiderm
growth
factor
receptor
egfr
degrad
lysosom
ligand
bind
receptor
activ
egfr
lysosom
target
depend
ligandstimul
ubiquitin
cytoplasm
domain
bind
egf
egfr
caus
downstream
signal
clathrinmedi
intern
trayck
endosom
intern
receptorligand
complex
sort
late
endosom
multivesicular
bodi
mvb
eventu
deliv
content
lysosom
katzmann
et
al
wherea
receptor
tfr
recycl
plasma
membran
egfr
move
endosomelysosom
system
ubiquitindepend
sort
recognit
system
includ
hrsstam
heterodim
bilodeau
et
al
present
endosom
membran
tumor
suppressor
gene
mutat
nearli
breast
cancer
patient
encod
membraneassoci
protein
lee
feinberg
factor
particip
sort
ubiquitin
protein
endosom
exact
function
clear
special
cell
cytotox
lymphocyt
ctl
platelet
melanocyt
regul
secret
rout
compart
tgn
cell
evolv
mechan
wherebi
modifi
secretori
lysosom
releas
content
plasma
membran
respons
extracellular
stimuli
secretori
lysosom
sl
share
lysosom
characterist
acid
ph
lamp
lysosomeassoci
membran
protein
resid
also
contain
uniqu
marker
tyrosinas
present
melanosom
ctl
secretori
lysosom
contain
uniqu
compon
perforin
granzym
requir
trigger
apoptosi
target
cell
ctl
contact
target
cell
sl
trayc
toward
immunolog
synaps
form
ctl
target
cell
signal
caus
sl
fusion
ctl
plasma
membran
stinchcomb
et
al
releas
sl
content
subsequ
target
cell
death
number
autosom
genet
diseas
caus
immunodefici
albin
involv
defect
regul
lysosom
secret
stinchcomb
et
al
rare
fatal
diseas
famili
hemophagocyt
lymphohistiocytosi
fhl
sl
congreg
plasma
membran
ctl
dock
fuse
membran
one
group
fhl
patient
diseas
due
mutat
gene
encod
close
relat
neuron
gene
product
involv
snare
complex
format
neuron
cell
feldmann
et
al
assembl
neuron
synaptobrevin
complex
regul
bind
lock
tsnare
close
inact
conform
thu
prevent
interact
yang
et
al
howev
sassa
et
al
rim
protein
evector
koushika
et
al
compet
displac
reinforc
open
conform
allow
snare
complex
format
occur
may
act
conform
switch
promot
tsnare
open
state
thu
allow
format
snare
complex
mediat
synapt
vesicl
dock
fusion
observ
fhl
patient
one
specul
role
similar
regul
snare
complex
format
sl
dock
fusion
ctl
yang
et
al
chediakhigashi
syndrom
ch
key
exampl
diseas
avect
sl
function
ctl
patient
display
hypopigment
stinchcomb
et
al
ch
patient
genet
mutat
lyst
gene
barbosa
et
al
perou
et
al
produc
ctl
contain
strikingli
enlarg
sl
abl
polar
immunolog
synaps
unabl
fuse
pm
suggest
role
gene
product
regul
membran
dock
fusion
overexpress
lead
presenc
small
lysosom
indic
increas
lysosom
fission
ward
et
al
addit
interact
snare
protein
indic
role
sl
fusion
tchernev
et
al
griscelli
syndrom
patient
also
display
defect
sl
dynam
within
ctl
exhibit
hypopigment
silveri
hair
melanocyt
cell
respons
pigment
storag
product
requir
recruit
melanophilin
pigment
granul
call
melanosom
sl
melanophilin
bind
myosin
motor
protein
myosin
va
regul
melanosom
movement
along
actin
cabl
plasma
membran
strom
et
al
wu
et
al
type
griscelli
syndrom
patient
gtpase
miss
defect
wherea
type
griscelli
syndrom
patient
myosin
va
motor
protein
absent
defect
also
evid
mous
model
ashen
defect
dilat
myosin
va
defect
leaden
melanophilin
defect
human
griscelli
syndrom
mous
model
melanosom
cluster
perinuclear
locat
defect
attribut
dysfunct
wilson
et
al
wu
et
al
interestingli
ctl
isol
type
griscelli
syndrom
patient
ashen
mice
defici
unabl
kill
target
cell
wherea
type
griscelli
syndrom
patient
dilat
mous
ctl
function
suggest
interact
diver
evector
induc
sl
fusion
plasma
membran
diver
cell
type
haddad
et
al
hermanskypudlak
syndrom
hp
fourth
exampl
sl
dysfunct
character
oculocutan
albin
ceroid
deposit
excess
prolong
bleed
hermanski
pudlak
swank
et
al
howev
hp
view
singl
diseas
group
least
seven
autosom
genet
disord
seven
subgroup
due
mutat
individu
gene
encod
compon
multisubunit
protein
complex
involv
vesicl
trayck
wherea
function
other
remain
unclear
three
complex
term
bloc
biogenesi
lysosomerel
organel
complex
play
role
regul
trayck
involv
platelet
melanosom
secret
exact
function
unclear
di
pietro
dellangelica
patient
nonsens
mutat
gene
encod
subunit
adaptor
protein
prevent
express
subunit
huiz
et
al
previous
mention
involv
recruit
transmembran
protein
vesicl
earli
endosom
deliveri
lysosom
peden
et
al
melanocyt
deriv
patient
tyrosinas
catalyz
format
melanin
transport
matur
melanosom
huiz
et
al
lead
characterist
pattern
albin
seen
patient
condit
furthermor
patient
display
impair
ctl
respons
immun
respons
ctl
patient
lytic
granul
move
orient
fashion
toward
microtubuleorgan
center
therefor
ctl
stimul
contact
target
cell
lytic
granul
target
immunolog
synaps
cell
kill
studi
cell
biolog
hiv
infect
suggest
exist
viral
secretori
compart
work
marsh
other
pelchenmatthew
et
al
local
viral
envelop
matrix
protein
tetraspaninposit
endosomerel
organel
infect
macrophag
dendrit
cell
viral
secretori
compart
move
intracellular
local
infecti
synaps
infect
macrophag
dendrit
cell
form
immunolog
synaps
activ
cell
may
one
mechan
subsequ
viral
infect
cell
thu
caus
impair
immun
respons
seen
patient
acquir
immunodefici
syndrom
aid
cell
requir
highli
organ
framework
cytoskeleton
station
move
membran
organel
within
threedimension
space
compon
cytoskeleton
guid
organel
vesicl
specif
destin
within
cell
microtubul
cytoskeleton
commonli
associ
direct
movement
intracellular
transport
vesicl
intermedi
contrast
actin
envis
structur
role
determin
cell
shape
plasma
membran
dynam
cell
locomot
howev
evid
point
role
actin
regul
trayck
tgn
allan
et
al
badizadegan
et
al
cobbold
et
al
endocytosi
ascough
engqvistgoldstein
drubin
cytoskeleton
dynam
structur
liken
collaps
scavold
rapidli
disassembl
reconstitut
depend
cellular
requir
actin
tubulin
polymer
elong
depolymer
breakdown
reli
control
addit
remov
monom
polar
energydepend
manner
protofila
either
structur
polar
plu
end
grow
faster
rate
actin
cabl
compos
two
parallel
protofila
twist
around
wherea
microtubul
compos
hollow
cylindr
structur
compris
parallel
protofila
actin
nucleat
initi
step
requir
elong
involv
format
stabl
trimer
subunit
base
protofila
elong
heptamer
complex
term
actinrel
protein
bind
end
side
actin
filament
nucleat
acceler
growth
actin
network
millard
et
al
function
complex
regul
membraneassoci
rho
gtpase
regul
includ
variou
rac
isoform
act
molecular
switch
cycl
activ
gtpbound
state
inact
gdpbound
state
regul
indirectli
downstream
target
wiskottaldrich
syndrom
protein
wasp
bind
directli
complex
jave
hall
patient
xlink
wiskottaldrich
syndrom
display
mutat
wasp
gene
thrombocytopenia
reduc
platelet
count
eczema
recurr
infect
hematolog
malign
autoimmun
disord
lemahieu
et
al
approxim
diseas
mutat
wasp
report
lead
defect
control
wasp
actin
polymer
sever
diseas
phenotyp
burn
et
al
wasp
express
restrict
hematopoiet
cell
although
ubiquit
express
nwasp
present
variou
cell
tissu
burn
et
al
actin
network
import
format
immunolog
synaps
cytotox
lymphocyt
ctl
target
well
lymphocyt
antigenpres
cell
macrophag
format
immunolog
synaps
ctl
essenti
transport
dock
fusion
sl
subsequ
destruct
target
cell
describ
defect
wasp
inhibit
format
immunolog
synaps
cell
activ
notarangelo
och
probabl
caus
immunolog
defici
observ
wiskottaldrich
syndrom
patient
wasp
defici
lymphocyt
also
avect
regul
composit
lipid
raft
dupr
et
al
indic
cell
biolog
membran
traffick
human
diseas
format
immunolog
synaps
depend
lipid
raft
wasp
actin
dynam
motor
protein
provid
physic
forc
move
membran
vesicl
along
polymer
cytoskelet
filament
via
atpdepend
hydrolysi
actinbas
motor
protein
belong
myosin
superfamili
myosin
va
gene
mutat
small
number
patient
griscelli
syndrom
bahadoran
et
al
pastur
et
al
trayck
mutat
contribut
griscelli
syndrom
discuss
section
vc
mutat
myosin
viia
gene
caus
usher
syndrom
result
blind
deaf
intracellular
transport
probabl
compromis
usher
syndrom
patient
mous
shaker
model
mutant
myosin
viia
gene
display
defect
melanosom
transport
retin
pigment
epitheli
cell
liu
et
al
alter
distribut
photoreceptor
cell
richardson
et
al
microtubul
motor
protein
activ
move
vesicl
along
microtubul
microtubuleassoci
protein
map
serv
dock
molecul
bind
cargo
motor
protein
gerd
katsani
microtubul
motor
protein
belong
either
kinesin
dynein
famili
except
ctermin
kinesin
kinesinbas
motor
gener
transport
cargo
toward
plu
end
microtubul
wherea
dynein
minu
enddirect
motor
longrang
vesicular
transport
particularli
import
neuron
axon
reach
length
newli
synthes
lipid
secret
membraneassoci
protein
made
cell
bodi
longrang
direct
transport
crucial
replenish
constitu
presynapt
cleft
termin
end
axon
synapt
vesicl
plasma
membran
receptor
holzbaur
number
human
neurolog
diseas
link
mutat
microtubul
motor
associ
protein
lissencephali
greek
term
mean
smooth
brain
caus
sever
brain
malform
result
mental
retard
epilepsi
one
gene
mutat
diseas
origin
identifi
millerdiek
syndrom
patient
lissencephali
reiner
et
al
protein
regul
microtubul
motor
function
bind
glu
compon
dynactin
complex
bind
activ
dynein
smith
et
al
propos
regul
retrograd
axon
transport
anoth
gene
mutat
patient
lissencephali
doublecortin
microtubuleassoci
protein
bind
tubulin
stabil
microtubul
horesh
et
al
moor
et
al
kinesin
regul
transport
synapt
vesicl
precursor
along
neuron
axon
patient
charcotmarietooth
diseas
type
display
neuron
axon
degener
due
lossoffunct
mutat
motor
domain
alzheim
diseas
classic
sign
hyperphosphoryl
aggreg
microtubuleassoci
protein
tau
neuron
cell
tissu
tau
protein
influenc
vesicular
transport
ebneth
et
al
regul
attach
motor
microtubul
trinczek
et
al
one
theori
tau
protein
interfer
kinesindepend
transport
block
motor
access
microtubul
thu
slow
prevent
vesicl
movement
along
axon
mandelkow
et
al
moreov
earli
sign
alzheim
diseas
loss
synaps
retrograd
degener
neuron
complement
breakdown
intracellular
transport
disrupt
microtubulemedi
vesicular
trayck
may
also
caus
factor
neurodegen
phenotyp
huntington
diseas
diseas
caus
expans
polyglutamin
repeat
occur
brainenrich
protein
huntingtin
htt
demonstr
htt
enhanc
vesicular
transport
brainderiv
neurotroph
factor
bdnf
along
microtubul
gauthier
et
al
htt
local
cytoplasm
associ
vesicular
microtubulebas
trayc
abil
bind
huntingtinassoci
protein
li
et
al
protein
ayniti
dynactin
glu
subunit
engelend
et
al
dysfunct
polyqhtt
associ
diseas
state
may
disrupt
transport
bdnf
bind
block
deliveri
bdnf
vesicl
along
microtubul
gauthier
et
al
support
find
bdnf
level
decreas
brain
huntington
diseas
patient
ferrer
et
al
current
treatment
genet
disord
involv
address
symptom
rather
caus
end
mani
mild
form
disord
niemannpick
diseas
famili
hypercholesterolemia
control
diet
regimen
lifestyl
chang
contrast
lifethreaten
diseas
cystic
fibrosi
requir
extens
physiotherapi
pulmonari
exercis
loosen
prevent
mucu
accumul
within
lung
new
antidementia
drug
increasingli
success
treat
neurolog
disord
alzheim
diseas
drug
galantamin
donepezil
rivastigmin
memantin
target
posttransl
process
bapp
reduc
amyloid
deposit
prasher
famili
hypercholesterolemia
statin
treatment
common
strategi
reduc
plasma
ldl
cholesterol
level
target
hmgcoa
reductas
ratelimit
enzym
cellular
cholesterol
biosynthesi
furthermor
less
commonli
use
ldllower
drug
probucol
shown
success
buckley
et
al
administr
adrenalin
receptor
antagonist
bblocker
patient
cardiac
condit
longqt
syndrom
reduc
arrhythmia
risk
enzym
replac
therapi
ert
carri
patient
fabri
diseas
lysosom
storag
diseas
patient
given
recombin
lysosom
agalactosidas
mignani
cagnoli
reduc
risk
stroke
kidney
failur
associ
condit
final
organ
transplant
occasion
carri
diseas
state
exampl
bone
marrow
transplant
chediakhigashi
syndrom
patient
liang
et
al
patient
griscelli
syndrom
schuster
et
al
wiskottaldrich
syndrom
filipovich
et
al
howev
although
transplant
oper
success
allevi
immunolog
issu
associ
diseas
address
problem
associ
nervou
system
pigment
b
gene
therapi
next
gener
medic
treatment
complet
human
genom
sequenc
project
given
scienc
abil
track
gene
respons
potenti
genet
disord
consequ
allow
gene
correct
patient
goal
gene
therapi
research
cours
gene
therapi
fundament
limit
realli
suitabl
singlegen
defect
diseas
multigen
chromosom
defect
beyond
abil
techniqu
complex
natur
diseas
howev
singl
gene
defect
caus
human
diseas
mani
diseas
requir
approach
histori
gene
therapi
discuss
detail
russel
scollay
much
evort
made
develop
techniqu
allow
success
replac
augment
defect
gene
gene
therapi
perform
introduc
gene
vehicl
directli
patient
vivo
remov
cell
patient
introduc
gene
cell
cultur
replac
cell
back
patient
ex
vivo
studi
focus
use
viral
vector
deliveri
vehicl
retrovirus
potenti
best
gene
deliveri
system
kurian
et
al
rna
virus
abl
infect
great
mani
cell
type
replic
insert
viral
gene
genom
host
host
cellular
machineri
modul
produc
assembl
viral
particl
gene
therapi
retrovirus
could
use
express
target
gene
replac
modifi
prevent
viral
diseas
hiv
caus
agent
aid
also
retroviru
princip
drawback
retroviru
vector
possibl
genom
integr
could
elev
oncogen
express
thu
caus
cancer
therefor
major
clinic
trial
use
retroviru
vector
perform
ex
vivo
success
gene
therapi
experi
exemplifi
case
femal
patient
lack
adenosin
deaminas
ada
result
sever
compromis
immunodefici
adascid
dysfunct
cell
blaes
et
al
case
retrovir
vector
use
deliv
code
sequenc
ada
cell
result
success
express
enzym
hitherto
defect
cell
although
success
uncertain
whether
enzym
replac
treatment
recombin
ada
inject
also
influenc
patient
outcom
adenoviru
adv
mcconnel
imperial
dna
viru
key
gene
therapi
vehicl
maintain
viral
genom
separ
transmiss
episom
within
nuclei
infect
host
cell
use
attenu
inactiv
adv
human
gene
deliveri
attract
much
interest
advantag
adv
gene
transfer
genom
easili
manipul
recombin
viru
grown
high
titer
vitro
eycient
transduct
target
cell
vitro
vivo
adv
evect
infect
nondivid
cell
lung
pulmonari
tissu
popular
vector
choic
gene
therapi
treat
cystic
fibrosi
cf
patient
although
promis
studi
zabner
et
al
failur
also
note
knowl
et
al
major
disadvantag
advbas
approach
trigger
strong
host
immun
respons
viru
becom
seriou
problem
subsequ
longterm
deliveri
recombin
viru
diseas
allevi
one
approach
circumv
issu
use
viral
deliveri
system
produc
low
host
immun
respons
adenoassoci
viru
aav
flott
aav
nonpathogen
viru
requir
coinfect
helper
viru
replic
howev
aav
broad
host
cell
specif
diycult
grow
larg
quantiti
probabl
relianc
helper
viru
final
nonvir
method
increasingli
avail
deliveri
dna
construct
directli
cell
tissu
often
lipidbas
reagent
eg
liposom
bind
plasmid
dna
fuse
plasma
membran
thu
enabl
cytosol
deliveri
gene
plasmid
dna
would
transport
host
nucleu
endogen
cellular
machineri
type
gene
deliveri
perform
ex
vivo
limit
poor
dna
transfect
eycienc
primari
cell
tissu
type
method
howev
potenti
use
method
deliv
gene
progenitor
precursor
eg
stem
cell
cellular
cell
biolog
membran
traffick
human
diseas
diverenti
tissu
format
within
particular
microenviron
bodi
mendel
et
al
numer
diseas
state
caus
protein
misfold
within
er
lead
degradat
ion
tabl
section
iii
one
strategi
would
promot
correct
protein
conform
mutant
gene
product
either
chemic
pharmacolog
number
membranedivus
chemic
pharmacolog
chaperon
identifi
could
avect
protein
fold
cell
chemic
chaperon
glycerol
trimethylamin
noxid
tmao
restor
wildtyp
trayck
activ
cultur
epitheli
cell
brown
et
al
porcin
kidney
epitheli
cell
express
treat
dimethyl
sulfoxid
dmso
increas
plasma
membran
level
channel
protein
bebok
et
al
loo
et
al
demonstr
novel
quinazolin
deriv
specif
cftr
rescu
defect
trayck
cultur
cell
cell
surfac
level
water
channel
enhanc
dmso
tamarappoo
verkman
defect
gene
result
xlink
nephrogen
diabet
insipidu
condit
patient
unabl
concentr
urin
inabl
reabsorb
water
kidney
blood
although
chemic
chaperon
somewhat
nonspecif
action
protein
fold
whole
cell
avect
target
protein
pharmacolog
chaperon
tailor
individu
protein
exampl
compound
nonpeptid
vasopressin
receptor
antagonist
morello
et
al
robert
et
al
patient
mutant
vasopressin
receptor
also
display
nephrogen
diabet
insipidu
treatment
cellperm
compound
would
act
chaperon
accompani
mutant
receptor
cell
surfac
rescu
correct
function
geldanamycin
natur
occur
antifung
agent
potenti
anticanc
drug
beliakov
whitesel
miyata
geldanamycin
interact
inhibit
activ
heat
shock
protein
chaperon
cytosol
cellular
stress
protein
support
correct
fold
stabil
function
client
protein
mani
client
protein
implic
cell
cycl
progress
prolifer
angiogenesi
whitesel
lindquist
tyrosin
kinas
complex
implic
regul
develop
epitheli
breast
tumor
client
inhibit
action
geldanamycin
result
degrad
downstream
signal
evector
result
reduc
cellular
growth
tumor
format
citri
et
al
number
cellperm
peptid
sequenc
found
virus
host
protein
discov
mediat
deliveri
cargo
protein
drug
plasmid
dna
oligonucleotid
directli
cell
brook
et
al
gupta
et
al
schwartz
zhang
peptid
sequenc
could
fuse
attach
recombin
engin
protein
administ
patient
complement
defect
particular
gene
product
exampl
drosophila
melanogast
antennapedia
homeodomain
antp
transcript
factor
contain
short
sequenc
mediat
protein
transloc
across
biolog
membran
bilay
energyindepend
manner
derossi
et
al
joliot
et
al
sourc
cell
membraneperm
protein
uncov
virus
replic
protein
tat
contain
basic
arginineand
lysinerich
peptid
sequenc
residu
modul
transloc
exogen
tat
across
plasma
membran
number
cell
type
abl
activ
intracellular
gene
control
hiv
promot
frankel
pabo
mann
frankel
basic
sequenc
intern
conjug
bgalactosidas
horseradish
peroxidas
fawel
et
al
well
fab
antibodi
fragment
anderson
et
al
major
structur
protein
herpesviru
trayc
cell
elliott
ohar
wherea
domain
hepat
b
viru
surfac
antigen
act
shuttl
peptid
function
protein
egfp
hepatocyt
cell
oess
hildt
suggest
exist
natur
occur
peptid
sequenc
may
act
drug
deliveri
vector
final
synthet
amphipath
peptid
fluosklalklalkalkaalklanh
shown
intern
mast
endotheli
cell
oehlk
et
al
employ
small
molecular
inhibitor
method
treat
human
diseas
move
exponenti
pace
number
compound
synthes
isol
nonhuman
organ
directli
avect
cellular
function
use
research
varieti
diseas
plantand
microorganismderiv
polyhydroxyl
alkaloid
refer
iminosugar
use
treatment
patient
gaucher
diseas
cox
et
al
gaucher
diseas
type
type
ii
lysosom
storag
disord
caus
mutat
gene
encod
cell
biolog
membran
traffick
human
diseas
acid
bglucosidas
gba
enzym
result
accumul
toxic
glucosylceramid
patient
spleen
liver
bone
manifest
enlarg
organ
well
heart
lung
diseas
iminosugar
act
glycosyl
enzym
present
within
er
golgi
inhibit
abil
transfer
sugar
moieti
onto
protein
one
member
iminosugar
famili
nbutyldeoxynojirimycin
nbdnj
also
call
miglustat
zavesca
inhibit
enzym
import
matur
gba
substrat
glucocerebrosid
name
ceramid
glucosyltransferas
cgt
butter
et
al
inhibit
cgt
result
significantli
reduc
level
glucocerebrosid
liver
spleen
patient
clinic
trial
cox
et
al
howev
nearli
patient
trial
display
osmot
diarrhea
side
evect
treatment
mous
model
human
taysach
diseas
caus
mutat
gene
encod
hexosamidas
level
harm
glycophospholipid
gm
significantli
reduc
treatment
nbdnj
platt
et
al
addit
treatment
lysosom
storag
diseas
nbdnj
deriv
call
miglitol
use
treatment
diabet
mellitu
result
reduc
activ
sucroseisomaltas
enzym
complex
reduct
carbohydr
digest
mitrak
et
al
major
aspect
human
diseas
product
subsequ
degrad
misfold
protein
either
proteasom
within
lysosom
lysosomotrop
agent
chloroquin
caus
increas
intralumen
ph
endosom
lysosom
reduc
lysosom
proteas
activ
trayck
protein
endosomelysosom
system
number
proteasom
inhibitor
lactacystin
alln
specif
inhibit
activ
rang
serin
cystein
proteas
chymotrypsinlik
enzym
kisselev
goldberg
proteasom
inhibit
link
number
aspect
human
diseas
treatment
endotheli
cell
proteasom
inhibitor
result
apoptosi
prolifer
cell
drexler
et
al
inhibit
plasminogen
activ
level
factor
promot
angiogenesi
new
blood
vessel
sprout
oikawa
et
al
howev
inhibit
proteasom
function
broad
cytotox
apoptot
evect
cell
tissu
chemotherapeut
agent
target
signal
pathway
current
much
interest
relat
cancer
therapeut
cellular
prolifer
regul
growth
factor
bind
cell
surfac
receptor
signal
either
mitogenactiv
protein
kinas
mapk
cascad
activ
pathway
induc
express
oncogen
cjun
cfo
inhibit
apoptosi
sequenc
protein
phosphoryl
event
shelton
et
al
demonstr
inhibit
mapk
pathway
small
molecul
inhibitor
specif
mek
reduc
cell
prolifer
induc
apoptosi
condit
transform
hematopoiet
cell
howev
pathway
also
regul
cellular
function
besid
prolifer
apoptosi
like
consequ
cellular
homeostasi
structur
studi
import
develop
new
small
molecul
inhibitor
target
specif
enzym
regul
cakt
pkb
serin
threonin
protein
kinas
requir
surviv
prolifer
mani
human
cancer
structur
elucid
kumar
madison
yang
et
al
refer
enc
therei
n
chem
otherap
utic
agent
consequ
design
inhibit
cakt
activ
molecul
target
atpbind
pocket
cakt
kumar
madison
compound
bind
specif
cakt
isoform
target
specif
domain
within
kinas
report
barnett
et
al
report
clinic
trial
compound
kumar
madison
final
small
molecul
inhibitor
develop
target
posttransl
process
protein
peptid
implic
human
diseas
enzym
catalyz
initi
step
bamyloid
synthesi
gsecretas
attract
target
prevent
amyloid
deposit
alzheim
diseas
patient
churcher
beher
small
molecul
inhibitor
could
also
use
treat
pathogen
infect
caus
sever
acut
respiratori
syndrom
sar
influenza
hiv
hepat
c
virus
attract
target
virusencod
host
proteas
requir
process
viral
protein
gener
infecti
viru
particl
host
cell
case
sar
viru
viral
chymotrypsinlik
cystein
proteas
respons
process
sar
viral
protein
requir
viral
replic
inhibit
proteas
would
evect
inhibit
viral
replic
molecul
refer
found
inhibit
replic
human
sar
toxic
evect
normal
cell
dooley
et
al
much
work
also
carri
target
host
proteas
requir
process
hiv
envelop
glycoprotein
biosynthet
secretori
pathway
gener
viral
polypeptid
complet
human
genom
sequenc
project
led
predict
larg
number
diseas
identifi
understood
gene
level
note
review
number
exampl
exist
singl
gene
mutat
devast
evect
human
function
present
symptom
mild
form
genet
diseas
modul
diet
drug
regimen
success
achiev
organ
transplant
gene
therapi
attract
much
attent
suver
setback
due
viral
toxic
issu
altern
strategi
use
small
molecul
therapeut
cell
biolog
membran
traffick
human
diseas
may
overrid
specif
defect
target
specif
pathway
compens
gene
defect
addit
understand
respond
genet
level
patholog
infect
enabl
us
design
evect
drug
strategi
present
chronic
infect
essenc
understand
cell
biolog
basi
human
diseas
enabl
us
design
evect
method
deliv
therapeut
strategi
patient
